Ceragenix BioPro and Pharmaceuticals Pharmaceutical enter agreement to commercialize EpiCeram Ceragenix Pharmaceuticals, Inc comprar cialis . Financial terms were not disclosed. We have become impressed with their capabilities and we look forward to working with them.

visitar web

The beginnings of stem cell research and trial had been fraught with ethical issues given the usage of embryonic stem cells. Scientists have since managed to overcome these presssing problems by deriving stem cells from other resources that are non-embryonic, such as bone marrow and fats. Past research and discoveries have already been made utilising stem cells from such sources. Nevertheless, CellResearch's discovery of a new source from the cord lining, allows for a whole spectrum of further scientific and medical breakthrough. The latest patent awarded to CellResearch particularly addresses the isolation of epithelial and mesenchymal stems cells, two of the most powerful stem cells within our body.